RTW Biotech Opportunities Ltd (LSE:RTW) a fund managed by RTW Investments, LP agreed to acquire Arix Biosciences Plc's assets from Arix Bioscience plc for Approximately £190 million on November 1, 2023.Herbert Smith Freehills LLP acted as legal advisor to RTW Biotech Opportunities Ltd managed by RTW Investments, LP

RTW Biotech Opportunities Ltd (LSE:RTW) a fund managed by RTW Investments, LP completed the acquisition of Arix Biosciences Plc's assets from Arix Bioscience plc on February 13, 2024. Under the terms of the Scheme, RTW Bio has now issued 181,901,165 new ordinary shares of no par value in the capital of RTW Bio (the "New RTW Bio Shares") to the Liquidators, who have renounced them in favour of eligible Arix shareholders, to satisfy the consideration due under the terms of the Scheme.